President (Founder)
CurrentIn transition from Germany back to the U.S.A. Presently accepting limited consulting and Board-level engagements in the bio-pharmaceutical space with a focus on rare diseases/orphan drugs.
Please complete the CAPTCHA to continue
area 561
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Robert Lefebvre is listed as President (Founder) at RDL & Associates, LLC at RDL & Associates, LLC, based in Delray Beach, Florida, United States. AeroLeads shows phone signal with area code 561 and a matched LinkedIn profile for Robert Lefebvre.
Robert Lefebvre previously worked as President (Founder) at Rdl & Associates, Llc and Vice President, Head of Global Strategy at Biotest Ag. Robert Lefebvre holds B.Sc., Human Anatomy from Mcgill University.
Dynamic commercial and strategy leader in the biopharmaceutical space with extensive domestic and international senior leadership experience including P&L accountable. Proven record of success in consistently delivering superior financial results in highly competitive and reimbursement dependent markets across a wide range of therapeutic categories and across the globe. Demonstrated ability to achieve increasing stakeholder value with small, mid-sized and large companies across orphan drugs, specialty biopharmaceuticals as well as Rx drugs. Dual US / Canadian citizen, fluent in English and French and working knowledge of Spanish and German.Corporate Strategy • Sales & Marketing Leadership • Cultural & Change Management • Market Access • International Business • Global Brand & Market Development • Business Development
Listed skills include Pharmaceutical Industry, Clinical Development, Sales, Biotechnology, and 32 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
In transition from Germany back to the U.S.A. Presently accepting limited consulting and Board-level engagements in the bio-pharmaceutical space with a focus on rare diseases/orphan drugs.
Dreieich, Hessen, De
Promoted to newly-created role with immediate task of leading creation of Biotest’s Strategic Roadmap for next 10 years, leading BD efforts and strengthening Global Marketing.
Recruited to Biotest Pharmaceuticals Corporation (BPC), to effect complete turn-around of US commercial business, focused on rare, orphan drug therapies. Oversaw sales, marketing, customer service and operations, business analytics and contracting. • Re-built sales and marketing team, re-directed go-to-market strategy and achieved 100% increase in end user Rx’s of key brand.
Responsible for full P&L (general management accountability of marketing, sales, finance, medical affairs, HR) across all therapeutic areas. Charged with expansion of Kedrion footprint across all countries. • Turned consistently money losing division into profitable contributor to Group EBITDA within 18 months of arriving.• Integrated and re-invigorated major new global brand asset purchased from another company.• Established new business models (legal entity or representative offices) in strategic markets across Europe and Asia. • Built management systems and leadership team capable of handling rapidly expanding, multi-national business. • Achieved over 30% growth in revenues annually.
Melbourne, Victoria, Au
- doubled sales to over $1 billion in 5 years- launched 6 new products
King Of Prussia, Pennsylvania, Us
• Developed strategic roadmap for expansion of firm across wide range of outsourced services aimed at biopharmaceutical industry.• Launched first-in-industry partnership, “The Biomarker Alliance”, collaborative process that promised to deliver best-in-class biomarker expertise to biotech companies. • Re-engineered and geographically centralized the marketing communications process across three business units resulting in consistency across units.
Lawrence Township, Nj, Us
Full accountability (in partnership with Development Champion) for the clinical development, regulatory submission strategy, pre-marketing, opinion leader development and commercial launch of JAVLOR (vinflunine), a licensed-in oncology product. Responsibility also included management of alliance governance structure.• Built Full Development team.• Led commercial and development planning discussions with in-licensed partner.• Developed and presented Target Product Profile (TPP) and Full Development Plan to executive steering committee leading to “go” decision on plan.
Basel, Basel-Stadt, Ch
Resposnible for all sales force and field based activities
Account Supervisor for pharmaceutical advertising at Ciba-Geigy, Fisons, Sterling-Winthrop
Launched the branded division of SynCare
Quick answers generated from the profile data available on this page.
Robert Lefebvre works for RDL & Associates, LLC.
Robert Lefebvre is listed as President (Founder) at RDL & Associates, LLC at RDL & Associates, LLC.
AeroLeads has found 1 phone signal(s) with area code 561 for Robert Lefebvre at RDL & Associates, LLC.
Robert Lefebvre is based in Delray Beach, Florida, United States while working with RDL & Associates, LLC.
Robert Lefebvre has worked for Rdl & Associates, Llc, Biotest Ag, Biotest Pharmaceuticals Corporation, Kedrion International Gmbh, and Csl Behring.
You can use AeroLeads to view verified contact signals for Robert Lefebvre at RDL & Associates, LLC, including work email, phone, and LinkedIn data when available.
Robert Lefebvre holds B.Sc., Human Anatomy from Mcgill University.
Robert Lefebvre is listed with skills including Pharmaceutical Industry, Clinical Development, Sales, Biotechnology, Pharmaceutical Sales, Oncology, Global Marketing, and Marketing.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts